Pivmecillinam – Oral Products
|
Minimum Inhibitory |
Disk Diffusiona |
||||
---|---|---|---|---|---|---|
Pathogenb |
S |
I |
R |
S |
I |
R |
Enterobacteralesc |
M100 standard is recognized |
S = susceptible; I = intermediate; R = resistant
a For disk diffusion, use paper disks impregnated with 10 mcg mecillinam.
b Susceptibility interpretive criteria are based on a dose of 185 mg pivmecillinam orally three times a day.
c Clinical efficacy was shown for Escherichia coli and Proteus mirabilis in patients with uncomplicated urinary tract infections.